, Tracking Stock Market Picks
Enter Symbol:
Sanofi-aventis Sa (SNY) [hlAlert]

down 3.89 %

Sanofi-aventis Sa (SNY) rated Buy by Berenberg

Posted on: Wednesday,  Aug 7, 2013  8:25 AM ET by Berenberg

Berenberg rated Buy Sanofi-aventis Sa (NYSE: SNY) on 08/07/2013, when the stock price was $52.11. Since
then, Sanofi-aventis Sa has lost 3.90% as of 01/26/2016's recent price of $50.08.
If you would have followed this Berenberg's recommendation on SNY, you would have lost 3.89% of your investment in 902 days.

Sanofi-Aventis is a pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products. The Company's business includes two main activities: pharmaceuticals and human vaccines through sanofi pasteur. In its pharmaceutical activity, Sanofi-Aventis specializes in six therapeutic areas: thrombosis, cardiovascular, metabolic disorders, oncology, central nervous system (CNS) and internal medicine. The Company offers vaccines in five areas: pediatric combination vaccines, influenza vaccines, adult and adolescent booster vaccines, meningitis vaccines, and travel and endemic vaccines. On September 1, 2008, Sanofi-Aventis acquired the Australian company, Symbion CP Holdings Pty Ltd (Symbion Consumer). On September 25, 2008, it acquired Acambis plc. In January 2009, the Company sold its French plant of Colomiers to French pharmaceutical company Unither. In April 2009, the Company acquired Mexican generic company, Laboratorios Kendrick.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/7/2013 8:25 AM Buy
as of 12/13/2013
1 Week down  -2.68 %
1 Month down  -6.20 %
3 Months up  3.62 %
1 YTD down  -4.62 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy